Anumana
AI that finds heart disease in a standard ECG
Ranked #9 in Best Medical Device Startups Using AI.
Anumana makes ECG-AI algorithms that detect heart conditions, including low ejection fraction, pulmonary hypertension and cardiac amyloidosis, from a standard 12-lead ECG.
At a glance
| Price from | Custom |
| Best for | Health systems screening for hidden heart disease |
From Anumana's own website.
What stands out
- Three FDA-cleared algorithms
- Uses a test hospitals already run
Worth knowing
- Funding not widely disclosed
- Early commercial stage
How it ranks
Anumana is ranked 9th of 10 in Best Medical Device Startups Using AI (Lister Score 86.6).
#9 in Best Medical Device Startups Using AI · Lister Score 86.6
Anumana received FDA clearance for its pulmonary hypertension algorithm in March 2026 and its cardiac amyloidosis algorithm in April 2026..
| Rank | Best Medical Device Startups Using AI | Score |
|---|---|---|
| 1 | Aidoc | 96.9 |
| 2 | Exo | 95.6 |
| 3 | Eko Health | 94.3 |
| 4 | Viz.ai | 93.1 |
| 5 | Cleerly | 91.8 |
| 6 | Prenuvo | 90.5 |
| 7 | Ultromics | 89.2 |
| 8 | Qure.ai | 87.9 |
| 9 | Anumana | 86.6 |
| 10 | Proprio | 85.3 |
Frequently asked questions
How does Anumana rank on Lister?
Anumana is ranked 9th of 10 in Best Medical Device Startups Using AI (Lister Score 86.6).
Appears in
Add this badge to your site
If you work at Anumana, paste this code into your website to show where it ranks on Lister. The badge links to the ranking and updates within a day when the rank changes.